Finance
Dietary supplement maker reports cash reserves up, loss reduced, R&D on schedule
Published in Women's Health Weekly, October 10th, 2002
As of June 30, 2002, the Novogen Group had $22 million in cash reserves compared with $17 million for the previous corresponding period.
This was coupled with a 33% reduction of the net loss for the 12 months to $8.0 million, down from $11.9 million for the year ended June 30, 2001.
Directors said the cash boost to the group was achieved through a stringent cost-control program and the successful listing and financing in May 2002, of U.S. incorporated subsidiary Marshall Edwards, Inc., on the London Stock...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Menopause
Hormone replacement therapy does not appear to influence breast cancer detection - Obstetrics
Multiples born to older moms fare same as or better than those born to younger moms - Breast Cancer
Tamoxifen shows encouraging results for prevention, but risks still unclear - Contraception
Bone loss in Depo-Provera users largely reversible - Human Papillomavirus
Link to cervical lesions confirmed - Obstetrics
Women prone to repeat miscarriage show increased prevalence of insulin resistance - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
